• 4782 Citations
  • 34 h-Index
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Jae-Hoon Kim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles
Uterine Cervical Neoplasms Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Endometrial Neoplasms Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Korea Medicine & Life Sciences
Osteopontin Medicine & Life Sciences
Hysterectomy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

  • 4782 Citations
  • 34 h-Index
  • 134 Article
  • 8 Review article
  • 2 Comment/debate

ALDH1A2 is a candidate tumor suppressor gene in ovarian cancer

Choi, J. A., Kwon, H., Cho, H., Chung, J. Y., Hewitt, S. M. & Kim, J. H., 2019 Oct, In : Cancers. 11, 10, 1553.

Research output: Contribution to journalArticle

Open Access
Tumor Suppressor Genes
varespladib methyl
Ovarian Neoplasms
Cell Line
1 Citation (Scopus)

Combined treatment with modulated electro-hyperthermia and an autophagy inhibitor effectively inhibit ovarian and cervical cancer growth

Yang, W., Han, G. H., Shin, H. Y., Lee, E. J., Cho, H., Chay, D. B. & Kim, J. H., 2019 Jan 1, In : International Journal of Hyperthermia. 36, 1, p. 9-20 12 p.

Research output: Contribution to journalArticle

Uterine Cervical Neoplasms
Ovarian Neoplasms
6 Citations (Scopus)

An open-label, randomized, parallel, phase ii trial to evaluate the efficacy and safety of a cremophor-free polymeric micelle formulation of paclitaxel as first-line treatment for ovarian cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021)

Lee, S. W., Kim, Y. M., Cho, C. H., Kim, Y. T., Kim, S. M., Hur, S. Y., Kim, J. H., Kim, B. G., Kim, S. C., Ryu, H. S. & Kang, S. B., 2018 Jan 1, In : Cancer Research and Treatment. 50, 1, p. 195-203 9 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
9 Citations (Scopus)

A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254)

Chan, J. K., Brady, W., Monk, B. J., Brown, J., Shahin, M. S., Rose, P. G., Kim, J. H., Secord, A. A., Walker, J. L. & Gershenson, D. M., 2018 Aug, In : Gynecologic Oncology. 150, 2, p. 247-252 6 p.

Research output: Contribution to journalArticle

Disease-Free Survival
Antigen Receptors
5 Citations (Scopus)

Comparison of clinical features and outcomes in epithelial ovarian cancer according to tumorigenicity in patient-derived xenograft models

Eoh, K. J., Chung, Y. S., Lee, S. H., Park, S. A., Kim, H. J., Yang, W., Lee, I. O., Lee, J. Y., Cho, H., Chay, D. B., Kim, S., Kim, S. W., Kim, J. H., Kim, Y. T. & Nam, E. J., 2018 Jul 1, In : Cancer Research and Treatment. 50, 3, p. 956-963 8 p.

Research output: Contribution to journalArticle

Disease-Free Survival
Germ-Line Mutation
Ovarian epithelial cancer